207874 Patient tailored medicines: The impact of race and genetics on medicine

Tuesday, November 10, 2009: 12:45 PM

Myra Selby, Esq and Partner , Health Law, Ice Miller LLP, Indianapolis, IN
One of the more controversial elements of advancing technology is the use of race and genetics to help create more specific types of medicines that will help combat diseases and conditions that appear to be more prevalent within certain races or ethnic groups than in others. Considering the history of discrimination and inadequate treatment of individuals on the bases of race and gender in the United States, there is justifiable concern that race or gender-based treatment could be used to legitimate discrimination. On the other hand, there is substantial proof that the current method of creating medicines for the general public is problematic and could prevent effective treatments from reaching the marketplace. This presentation addresses the relevance of genetic information, and how race and genetics have affected and may impact the development of medicines, pharmacogenomics, and personalized medicine in the Untied States. This presentation also examines current and proposed federal and state laws and regulations intended to protect individuals from the misuse of genetic information, including the uses that discriminate based on genetic predispositions. We will also explore the potential for litigation and defenses against both manufactures and providers, as well as legal issues relating to research that relies on the use of genetic information.

Learning Objectives:
Explain current and proposed federal and state laws and regulations relevant to the topic. Discuss potential litigation issues for both manufacturers and providers. Discuss potential defenses for both manufacturers and providers. Identify legal issues relating to research that relies on the use of genetic information.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Myra Selby has a broad-based practice with a focus in the areas of appellate law, compliance counseling, business planning, complex litigation, risk management, strategic and other legal advice, based upon an understanding of the related business objectives, across various industry sectors including health care, insurance, and public administration.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.